Susquehanna Portfolio Strategies’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$335K Buy
168,443
+39,391
+31% +$56.9K 0.01% 733
2026
Q1
$164K Sell
129,052
-5,181
-4% -$9.75K ﹤0.01% 916
2025
Q4
$321K Sell
134,233
-96,112
-42% -$263K 0.01% 868
2025
Q3
$656K Buy
+230,345
New +$788K 0.01% 762

Other funds holding HCAT

Susquehanna Portfolio Strategies's HCAT Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Health Catalyst (HCAT) stake by 31% in Q2 2026, buying an estimated $56.9K and bringing the position to 168,443 shares worth $335K. The position accounts for 0.01% of the portfolio, ranked #733.

Susquehanna Portfolio Strategies first reported a position in HCAT in Q3 2025 and has held it in 4 quarters since. The position peaked at $656K in Q3 2025. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Susquehanna Portfolio Strategies held 168,443 shares of Health Catalyst worth $335K as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 39,391 Health Catalyst shares in Q2 2026, an estimated $56.9K.
  • Health Catalyst made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #733 holding.
  • Susquehanna Portfolio Strategies first reported a position in Health Catalyst in Q3 2025 and has held it in 4 quarters since.
  • Susquehanna Portfolio Strategies's Health Catalyst position peaked at $656K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.